Idaho Falls, ID, United States
Radnostix recalls
2 recalls recorded since 2018, most recently on 19 February 2026. 2 are listed as ongoing. Status and classification are as published by the FDA.
Recalls2
Ongoing (FDA)2
Terminated or completed0
Class I (FDA)0
Ongoing Class III Drugs
- Recall started
- 19 February 2026
- Reason
- Failed Tablet/Capsule Specifications
- Distribution
- Nationwide in the US, including Puerto Rico
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0401-2026
- Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, International Isotopes Inc., Idaho Falls, ID 83401. NDC: 69208-003-15; 69208-003
Ongoing Class II Drugs
- Recall started
- 26 January 2026
- Reason
- Presence of Particulate Matter: Due to production issues
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0389-2026
- Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.